# RKLB (Rocket Lab Corporation) — Updated Equity Research Note
**Date of Update:** 2026-05-22
**Prior Thesis Date:** 2026-05-10 (Conviction 7/10, "recommend")
**Current Price:** $135.76 | **Market Cap:** $78.6B
---
WHAT HAS CHANGED SINCE THE LAST THESIS (May 10, 2026)
**Market cap has expanded from ~$61B to $78.6B in ~12 days** (a ~29% move; 1M return is +70%).
**Revenue base unchanged at ~$0.7B TTM** (per yfinance) — meaning the entire move is multiple expansion, not fundamental re-rating. P/S is now **115.6x**, P/B **34.5x**.
**New $90M GEO satellite contract from U.S. Space Force** (GlobeNewswire, 2026-05-22) — a meaningful incremental win in the Space Systems segment and validates the SDA payload capability.
**9th successful Electron launch for Synspective** (Financial Post, 2026-05-22) — operational cadence intact.
**SpaceX IPO narrative is inflating the entire space complex** (PRNewswire, 2026-05-22) — sector beta is doing the heavy lifting here, not company-specific fundamentals.
**Analyst consensus target ($103.91) is now ~23% BELOW the current price** — for the first time in this thesis, the stock is trading meaningfully above the sell-side. That is a yellow flag.
**Bottom line on the change:** Fundamentals are tracking as expected (or slightly better with the $90M contract), but **valuation has run ahead of the thesis**. I am downgrading conviction and shifting status from "recommend" to "monitoring." This is not an abandonment of the long-term story — it is a valuation discipline call.
---
1. THESIS SUMMARY
Rocket Lab is a vertically integrated space company with two segments: **Launch Services** (Electron — operational; Neutron — medium-lift, targeting 2026 first flight) and **Space Systems** (satellite buses, components, optical systems, on-orbit operations). The company is the only credible Western pure-play alternative to SpaceX with both flight heritage *and* a satellite manufacturing platform — a structurally differentiated position in a sector where national security customers demand redundancy of supply.
The **core investment thesis** is that RKLB is core infrastructure for two secular tailwinds: (1) the U.S. defense/space supercycle driven by Space Force build-out, Golden Dome / missile defense, and proliferated LEO architectures; and (2) the commercial space economy, which is gaining real revenue traction (Synspective, BlackSky, government constellations). The **moat** is real but narrow: flight-proven launch cadence (Electron is the #2 most-launched U.S. orbital vehicle), vertical integration that competitors cannot easily replicate, and increasingly sticky satellite-bus customers including the U.S. Space Force.
What has *not* changed: the quality of the business. What *has* changed: the price you pay for it. At 115x sales and a market cap that prices in flawless Neutron execution and substantial Space Systems scaling, the margin of safety has compressed materially.
2. BULL CASE
**Neutron first flight and successful reusability** would unlock the medium-lift market (~$200M+ ASPs vs. Electron's ~$8M) and represent a 10x+ revenue-per-launch step-function. This is the single biggest catalyst.
**Defense/space supercycle is real and accelerating** — the $90M Space Force GEO contract (GlobeNewswire 2026-05-22) is evidence that RKLB is winning prime-contractor-scale awards, not just subcontracts. Golden Dome and SDA programs represent multi-billion-dollar TAM expansion.
**Space Systems is the underappreciated leg** — higher margin, more recurring, and growing faster than launch. If this segment scales to $1B+ with 40%+ gross margins, the current valuation becomes more defensible.
**SpaceX IPO catalyst** would re-rate the entire space sector with comparable public-market multiples, providing a sentiment tailwind through 2026 (PRNewswire 2026-05-22).
3. BEAR CASE
**Valuation is now extreme on any conventional metric.** P/S of 115x, P/B of 34.5x, and a market cap ($78.6B) that is **>23% above sell-side consensus target of $103.91** (16 analysts). The stock is pricing in Neutron success *and* Space Systems scaling *and* margin expansion. Any one of these slipping triggers multiple compression.
**Neutron execution risk is binary and historically delayed.** First flight has slipped multiple times. A launch failure or further slippage of 12+ months would severely impair the bull thesis at this valuation.
**Operating margin remains -22.4% and FCF is -$210M** (yfinance). Debt/Equity of 6.12x is elevated. The company is not yet self-funding, and at this valuation any dilutive equity raise is reasonable to expect but would still cap upside.
**Sector-wide sentiment risk:** A SpaceX IPO that prices poorly, or a broader risk-off rotation out of high-beta names (Beta 2.31), would disproportionately hit RKLB. The 1M move of +70% has created a crowded long.
4. EXIT CONDITIONS
I would **abandon or trim** the thesis if any of the following occur:
**Neutron first flight fails or is delayed beyond Q2 2027** without credible technical explanation.
**Revenue growth decelerates below 35% YoY** for two consecutive quarters without a corresponding margin step-up.
**Gross margin compresses below 30%** (currently 36.6%), suggesting pricing power erosion.
**Equity raise >15% of share count at a discount** — signals desperation rather than opportunistic capitalization.
**Loss of a major Space Force / national security contract** or evidence the U.S. government is consolidating awards back to SpaceX/ULA.
**Price exceeds $160 (~$92B cap)** without a fundamental catalyst — at that point I would actively trim regardless of thesis intact-ness, on valuation alone.
5. 5-YEAR EXPECTED OUTCOME RANGE
| Scenario | 5Y Price | CAGR | Assumptions |
|---|---|---|---|
| **Bear** | $50–70 | -12% to -7% | Neutron fails or delayed >2yrs; SpaceX IPO disappoints; sector multiple compression; revenue tops out at ~$2B with negative FCF |
| **Base** | $150–200 | +2% to +8% | Neutron operational by 2027; revenue scales to ~$4–5B by 2030; Space Systems hits 45% gross margin; FCF positive by 2028; multiple normalizes to ~10–15x sales |
| **Bull** | $300–400 | +17% to +24% | Neutron becomes recurring revenue stream; RKLB wins meaningful Golden Dome share; Space Systems scales to $3B+; positions as "the other SpaceX" with sustained 50%+ growth |
The **base case is now barely positive over 5 years from $135** — that is the core problem with adding here. The asymmetry has flipped from favorable (at ~$25 a year ago) to roughly symmetric.
---
RECOMMENDATION CHANGE
**Prior:** Recommend, 7/10 conviction (at $61B cap)
**Current:** **Monitoring, 5/10 conviction** (at $78.6B cap)
**Rationale:** The business is performing well — the $90M Space Force win and continued launch cadence reinforce the qualitative thesis. But valuation has expanded faster than fundamentals, the stock now trades above sell-side targets, and the 5-year base case offers limited upside from here. I am **not recommending new capital deployment at $135**. Existing positions held from lower cost basis remain valid (thesis is intact), but I would not chase. I will re-engage on a pullback to the $90–105 range or upon material Neutron progress.
```json